ARCHIVES

FDA Working On New Ground Rules For “Adaptive” Clinical Trial Designs.

This article is from The Cancer Letter archive.

Vol. 32 No. 27 | July 14, 2006

Download PDF Visit The Full Archive

Related Articles

In Brief: Construction Grant Transfer To USC Approved; Illinois Director Says NCI Pushed Consortia

January 20, 1978

Nexavar Improves PFS In Phase III Trial

January 25, 2013

Full Text Of NCI-Specific Language In House Report

July 31, 1992

Advocacy Groups Consider Pros And Cons Of Forming Co-Pay Foundations.

April 28, 2006

NCI Letter To Pittsburgh Details Deficiencies In NSABP Operations

April 8, 1994

In Brief: New Biomedical Research Panel To Organize Feb. 24-25, Discuss Mandate, Priorities

February 14, 1975